Hormones

Applications Norethindrone intermediate.
References Carlin, J., et al.: Drug Metab. Dispos., 20, 148 (1982), Hoffmann, R., et al.: Clin. Exp. Dermatol., 27, 373 (2002), Tarter, T., et al.: Curr. Pharm. Des., 2, 775(2006),

Applications A metabolite of 17α-Methyltestosterone (M326400).
References Dumasia, M., et al.: Xenobiotica, 11, 323 (1981), Tang, P., et al.: Anal. Biochem., 182, 289 (1989),

Applications Testosterone 17-Decanoate, is an ester of Testosterone (T155000). Testosterone 17-Decanoate, can be used as a potential long-acting male contraceptive, with the combination of subcutaneous etonogestrel implants .
References Brady, B. M., et al.: Human Reproduction, 21 (1), 285 (2006); Themmen, A., et al.: Endocr. Rev. 21, 551 (2000);

Applications Testosterone 17β-Carboxylic Acid is an intermediate in the synthesis of the drugs Dutasteride (D735000) and Finasteride.
References Brooks, J., et al.: Annu. Drug Data Rep., 14, 996 (1992), Lam, J., et al.: Urology, 61, 354 (2003), Tarter, T., et al.: Curr. Pharm. Des., 12, 775 (2006), Aggarwal, S., et al.: Steroids, 75, 109 (2010),

Applications Testosterone 17-Phenylpropionate, is one of the 17β-fatty acid esters of testosterone, that is increasingly misused by athletes in an attempt to improve sports performance, and thus can be used in doping control. It can also be used as a therapy in glucocorticoid-treated patients to increase the circulating testosterone concentration.
References Shackleton, C. H. L., et al.: Steroids, 62 (7), 523 (1997); Reid, I. R., et al.: Archives Internal Med., 156 (11), 1173 (1996);

Applications Testosterone (T155000) derivative.
References McFarland, K., et al.: Science, 245, 494 (1989), Heckert, L., et al.: Mol. Endocrinol., 12, 1499 (1998), Themmen, A., et al.: Endocr. Rev. 21, 551 (2000), Kumar, R., et al.: Biol. Reprod., 65, 710 (2001),

Applications Testololactone, is the derivative of Testolactone (T154800), which is an antineoplastic agent that is a derivative of progesterone and is used to treat advanced stage breast cancer.
References Dunkel, L.: Mol. Cell. Endocrinol., 254, 207 (2006); Eugster, E. A.: Treat. Endocrinol., 3, 141 (2004); Holbeck, S.L. et al.: Mol. Cancer Therap., 9, 1451 (2010);